Proteoglycans of 300000mol.wt. were isolated from dispersed rat basophil tumour cells after labelling of the sulphated mucopolysaccharides with 35S in vitro: 90% of the 35S-labelled mucopolysaccharides were extracted at high salt concentration. Alkali degradation of the 35S-labelled proteoglycans yielded glycosaminoglycan chains of 40000mol.wt. The composition of the salt-extracted 35S-labelled mucopolysaccharides, as defined by parallel or sequential degradation with chondroitinase AC, chondroitinase ABC and heparinase and resolution of the disaccharide-digestion products obtained with chondroitinase AC, was 48-61% chondroitin 4-sulphate, 20-30% dermatan sulphate, 10-15% heparin and 7-9% chondroitin 6-sulphate. Most of the salt-extracted 35S-labelled mucopolysaccharides were highly charged, with heparin and chondroitin 6-sulphate being relatively uniform in this regard, whereas chondroitin 4-sulphate and dermatan sulphate exhibited a range of charge characteristics. The diversity of sulphated mucopolysaccharides present in the rat leukaemic basophil is in contrast with the predominance of heparin in the rat mast cell.
Mast cells and basophils of every species studied contain granules that stain metachromatically (Selye, 1965a,b; Parwaresch, 1976) and have receptors for species-specific immunoglobulin E (Ishizaka & Ishizaka, 1975; Lichtenstein et al., 1978) . The sulphated mucopolysaccharides of both rat (Yurt et al., 1977a) and human (Metcalfe et al., 1978) mast cells are predominantly the proteoglycan heparin, as assessed by physicochemical and functional criteria. In the rat the proteoglycan heparin has been located in the secretory granule, on the basis of its release with histamine after immunological activation of the cell (Yurt et al., 1977b) .
Although the human neutrophil has been demonstrated to contain the proteoglycan chondroitin sulphate (Olsson, 1969) , the sulphated mucopolysaccharides of the basophil have not previously been described as proteoglycans, because either physicochemical characterization was not carried out (Olsson et al., 1970; Sue & Jaques, 1974) or the extraction procedure involved proteolytic treatment (Orenstein et al., 1978) , which would cleave a peptide core (Morrison, 1974) . Rat leukaemic basophils represent a homogeneous cell source (Eccleston et al., 1973) for isolation and characterization of cell-associated mucopolysaccharides. In addition, cultured cell lines derived from this tumour are being extensively used for studies of the immunoglobulin E receptor (Kulczycki et al., 1974; Conrad & Froese, 1978) and the release reaction (Siraganian & Metzger, 1978) . Whereas rat mast-cell mucopolysaccharides are predominantly the proteoglycan heparin (Yurt et al., 1977a) The uronic acid content of rat leukaemic basophils was determined by the modified carbazole reaction (Bitter & Muir, 1962 ) and compared with a known glucuronolactone standard. Histamine was quantified by bioassay on atropine-treated guineapig ileum (Brocklehurst, 1960) . Isolation, labelling and extraction ofbasophils Pooled rat basophil leukaemia tumour (Eccleston et al., 1973; Wasserman & Austen, 1977) (20-30g) was finely minced in Hanks' balanced salt solution to obtain a cell suspension for radiolabelling. After nylon-wool filtration of the minced fragments, 60-70% of the cell suspensions were well-differentiated basophils, the remaining 30-40% being poorly differentiated basophils, as recognized by phase-contrast microscopy, with and without vital staining with Toluidine Blue, or by light-microscopy of Giemsa-stained ethanol-fixed smears. Dispersed cells were sedimented at 400g for 10min at 220C and washed twice with Hanks' balanced salt solution. For radiolabelling, 3 x 100-8 x 108 cells were resuspended in 300-800ml of sulphate-free Eagle's minimum essential medium with Earle's salts containing 2 mmol of L-glutamine and 1 mCi of H235S04/100ml.
After incubation for 18h at 370C under 02/CO2 (19:1) (Hotpack Carbon Dioxide Incubator, Philadelphia, PA, U.S.A.), the cells were washed five times in Hanks' balanced salt solution, resuspended in 1.0M-NaCl at a concentration of 1 x 108 cells/ml, and disrupted by freezing and thawing six times.
After cell disruption, cell debris was sedimented by centrifugation at 400g for 10min at 220C. The supernatant containing the salt-solubilized extract was stored at 40C. The residual cell debris was suspended in 3-8ml of 0.5M-NaOH at 220C for 18h to solubilize the remaining 35S-labelled mucopolysaccharides by degradation to their glycosaminoglycans. After sedimentation at 400g for 10min at 220C, the supernatant containing the alkali-solubilized extract was stored at 40C.
Characterization of extracted 3"S-labelled mucopolysaccharides
The salt-solubilized and alkali-solubilized cell extracts were each dialysed against 40vol. of 1.OMNaCl for 18h at 40C, and separately applied to a column (1 cm x 5cm) of Dowex 1 equilibrated in 1.OM-NaCl. The columns were washed with 20ml of 1.0M-NaCl, and the 35S-labelled mucopolysaccharides eluted in stepwise fashion with 20ml of each of 3.0M-and 4.0M-NaCl (Schiller et al., 1961; Slorach, 1971) . The eluates were then dialysed against 40vol. of distilled water for 18 h at 4°C, freeze-dried and resuspended in 0.5 ml of distilled water. The combined 3.0M-NaCl and 4.0M-NaCl eluates from Dowex 1 were desalted further by filtration over Sephadex G-50 columns (1 cm x 60cm) equilibrated in water. All the radioactivity was in the excluded fractions, which were pooled, freeze-dried and stored at 40C as the starting material for physicochemical characterization or determination of susceptibility to enzyme degradation.
The apparent molecular weights of both saltextracted and alkali-extracted 3"S-labelled mucopolysaccharides were estimated by filtration over a previously standardized column (lcmx60cm) of Sepharose 4B equilibrated in 2M-NaCl at 220C. To define the charge characteristics, salt-extracted 35S-labelled mucopolysaccharides were applied to a DEAE-cellulose column (1 cm x 5cm) equilibrated in 0.01 M-sodium acetate (pH 5.5)10.1 M-LiCl, and eluted with sequential LiCl logarithmic gradients from 0.1 to 1.0M-and 1.0 to 2.0M-LiCl (Lewis et al., 1973; Yurt et al., 1977a) . The column was eluted at a rate of 10ml/h, and fractions of volume 2ml were collected.
To determine susceptibility to degradation by chondroitinase AC or ABC, samples of saltextracted and alkali-extracted 3"S-labelled mucopolysaccharides were suspended in 1 ml of 0.05M-Tris/HCl buffer, pH 7.6, containing 0.1 M-NaCl and 0.1% bovine serum albumin, with or without 1 unit of either chondroitinase AC or chondroitinase ABC (Yamagata et al., 1968) . Chondroitin 4-sulphate (250,ug) and chondroitin 6-sulphate (250,ug) were added to the mixture containing chondroitinase AC, and these standards plus 250,ug of dermatan sulphate were added to the enzyme-free reaction mixture or that containing chondroitinase ABC.
After 90min incubation at 37°C, the entire reaction mixture or a sample was subjected to Sephadex G-50 gel filtration as described for desalting the eluates from Dowex 1. 35S-labelled-mucopolysaccharide degradation was quantified by the change in elution of 35S, and degradation of the internal standard was established by the change in the filtration pattern of the uronic acid.
The relative amounts of chondroitin 4-sulphate and chondroitin 6-sulphate in one-half of the reaction mixture that resulted from chondroitinase AC degradation were determined by analysis of the disaccharide-digestion products. Portions of this mixture and known disaccharide standards were applied to Whatman no. 1 paper and subjected to descending chromatography in butanol/acetic acid/aq. hm-NH3 (2:3: 1, by vol.) for 12h at 220C (Saito et al., 1968) . After chromatography, the paper was cut into 1 cm squares, and 35S was assessed in a low-beta planchette counter (Beckman Instruments, Fullerton, CA, U.S.A.).
To determine the relative content of heparin, the chondroitinase ABC-resistant 35S-labelled mucopolysaccharides were pooled, freeze-dried and resuspended in 0.1M-sodium acetate buffer, pH7.0, containing 250pg of commercial porcine heparin, with or without 250,pg of purified heparinase (Hovingh & Linker, 1970) . After incubation for 90min at 300C, the samples were subjected to Sephadex G-50 gel filtration to determine the extent of degradation by heparinase.
Results

Identification of the 35S-labelled mucopolysaccharides
The salt-solubilized and alkali-solubilized extracts of 3 x 108 and 8 x 108 leukaemic basophils obtained from two separate minced tumour suspensions, designated 1 and 2, and containing 2,ug of histamine/108 cells were individually chromatographed on Dowex 1. The fractions eluted with 1.0M-NaCl, which are known to be free of sulphated mucopolysaccharides (Schiller et al., 1961) , contained more than 99% of the residual unincorporated precursor 35S and total protein (Yurt et al., 1977a; Slorach, 1971) . The relative amounts of 35S-labelled mucopolysaccharides in a portion of the salt-solubilized cell extracts in the combined 3.0M-and 4.0M-NaCI eluates were assessed by degradation with chondroitinase AC, followed by paper chromatography of the resulting disaccharides and by digestion with chondroitinase ABC followed by treatment with heparinase. Before enzyme treatment (Fig. la) , 35S-labelled mucopolysaccharides were excluded, as were internal chondroitin sulphate standards. Treatment with chondroitinase AC (Fig. lb) degraded all of the internal standards and 55% of the 35S-labelled mucopolysaccharides, and the latter consisted of 87% chondroitin 4-sulphate and 13% chondroitin 6-sulphate, as determined by paper chromatography. Chondroitinase ABC (Fig. lc) degraded 85%, indicating that 30% of the 35S-labelled mucopolysaccharide was composed of dermatan sulphate. The chondroitinase ABC-resistant "S-labelled mucopolysaccharides were degraded by heparinase (Fig.  2) . Table 1 Approximately two-thirds of the salt-solubilized 3"S-labelled mucopolysaccharides appeared in a broad peak with an average mol.wt. of 300000, estimated by Sepharose 4B gel filtration, and the remainder was eluted in a second peak coincident with and just after a commercial heparin marker of 12 000 mol.wt. When fractions were pooled, subjected to alkali hydrolysis to break xylosyl-serine bonds (Muir, 1958; Lindahl & Roden, 1966) , dialysed and refiltered on the same Sepharose 4B column, the 3"S-labelled mucopolysaccharides DEAE-cellulose chromatography of the salt-solubilized 35S-labelled mucopolysaccharides gave a peak of highly charged fractions (85-120) and a shoulder with less charged fractions (40-84) (Fig.  3) . Selective enzyme degradation revealed that the highly charged "S-labelled mucopolysaccharides in the peak consisted of 40% chondroitin 4-sulphate, 15% chondroitin 6-sulphate, 10% dermatan sulphate and 35% heparin, whereas the less highly charged 35S-labelled mucopolysaccharides were composed of 50% chondroitin 4-sulphate and 50% dermatan sulphate. Sepharose 4B gel filtration of the highly charged 35S-labelled mucopolysaccharides revealed two peaks of radioactivity eluted with molecular weights similar to that of the starting material (Fig. 4) .
Discussion
Proteoglycans were isolated by salt extraction from a homogeneous cell source composed of dispersed rat leukaemic basophils. More than 90% of the 35S-labelled mucopolysaccharides extracted were solubilized by high salt concentrations, and the remainder was solubilized by degradation in alkali. The salt-solubilized 35S-labelled mucopolysaccharides contained 300000-mol.wt. proteoglycans, with glycosaminoglycan side chains of 40000mol.wt. as assessed by Sepharose 4B gel filtration before and after hydrolysis with alkali. The sulphated mucopolysaccharides from leukaemic basophils, considering both salt-extracted and alkalisolubilized material, were comprised of 49-63% chondroitin 4-sulphate, 19-30% dermatan sulphate, 9-15% heparin and 7-9% chondroitin 6-sulphate (Figs. 1 and 2 and Table 1 ).
The salt-solubilized 35S-labelled mucopolysaccharides exhibited a wide range of charge heterogeneity, with two-thirds of the material being highly charged and being eluted from DEAE-cellulose just before and with commercial porcine heparin (Fig. 3) . The highly charged 35S-labelled mucopolysaccharides were eluted with an average mol.wt. of 300000, which is compatible with a proteoglycan structure Fig. 3 . DEAE-cellulose chromatography of salt-solubilized "IS-labelled mucopolysaccharides from rat leukaemic basophils after Dowex 1 chromatography Metachromasia by Azure A (E) represents commercial porcine heparin (3 mg) added as an internal standard; the column was previously standardized with porcine hyaluronic acid (2mg), whale chondroitin 4-sulphate (3mg), porcine dermatan sulphate (3mg), shark chondroitin 6-sulphate (3mg) and porcine commercial heparin (3mg). 0, Radioactivity. (Fig. 4) . Degradation studies revealed that the more highly charged 35S-labelled mucopolysaccharides contained all the heparin and chondroitin 6-sulChondroitin The presence of heparin among the sulphated Fraction no.
mucopolysaccharides of human basophils was in- coagulant activity in extracts of peripheral-blood
The markers Blue Dextran, chondroitin 6-sulphate, leucocytes (Martin & Roka, 1953; Amann & Martin, commercial heparin, and Phenol Red were filtered 1961). A human leukaemic basophil preparation of separately.
Vol. 185 25% purity resembled the rat leukaemic basophil (Table 1) in containing about 18% heparin, with the remainder of the sulphated mucopolysaccharides being chondroitin sulphates of unspecified types (Olsson et al., 1970 ). This conclusion was based upon the degradation by heparinase of both [35SIsul-phate-and ['4C]glucosamine-labelled chondroitinase ABC-resistant mucopolysaccharides. In contrast, the 35S-labelled glycosaminoglycans of basophil-enriched preparations of guinea-pig peripheralblood leucocytes were devoid of heparin but contained 15% heparan (Orenstein et al., 1978) . Further, although both guinea-pig basophils and rat leukaemic basophils contained 30% dermatan sulphate, the ratio of chondroitin 4-sulphate to chondroitin 6-sulphate was reversed, being 1:6 in the guinea pig and 6.7:1 in the rat. The absence of heparan from the rat leukaemic basophil is consistent with previous observations, in which permanent cell lines were shown to possess chondroitin sulphates rather than heparan (Mutoh et al., 1976; Dietrich et al., 1977) .
